Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open-label, Flexible-dose Study of Vortioxetine in Patients With Major Depressive Disorder in India

NCT04288895 is registered in ClinicalTrials.gov with H. Lundbeck A/S as lead sponsor.

NCT NCT04288895
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04288895 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open-label, Flexible-dose Study of Vortioxetine in Patients With Major Depressive Disorder in India
Lead sponsor
H. Lundbeck A/S
Phase
Phase 4
Overall status
Completed
Start date
February 20, 2020
Completion date
March 12, 2022
Enrollment
400 (actual)
Sites
24

Conditions

As the registry lists them; a condition with its own page is linked.

major depressive disorder